首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Reviews on recent clinical trials

缩写:

ISSN:1574-8871

e-ISSN:1876-1038

IF/分区:1.2/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引712
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
W Douglas Cress,Alberto Chiappori,Pedro Santiago et al. W Douglas Cress et al.
Hispanic/Latinos (H/L) are expected to grow to over 24% of the USA population by 2050 and lung cancer is the number one cause of cancer death among H/L men. Due to the information that is becoming available via genetic testing, lung cancer ...
Edna Mora,James A Robb,Gustavo Stefanoff et al. Edna Mora et al.
The 1st Puerto Rico Biobanking Workshop took place on August 20st, 2014 in the Auditorium of the Comprehensive Cancer Center of the University of Puerto Rico, Medical Sciences Campus in San Juan Puerto Rico. The program for this 1-day, live...
Courtney L Scherr,Elsa Vasquez,Gwendolyn P Quinn et al. Courtney L Scherr et al.
Background: Little is known about barriers to Hereditary Breast and Ovarian Cancer (HBOC) genetic counseling among Puerto Rican women. Objective: ...
Caroline B Appleyard,Scott J Antonia,Daniel M Sullivan et al. Caroline B Appleyard et al.
Barriers persist in the development and delivery of effective cancer therapies to under-represented minority populations. In Puerto Rico, cancer is the second leading cause of death, yet cancer research awareness and training opportunities ...
Maryam Torkan,Mohammad Hassan Entezari,Mansour Siavash Maryam Torkan
Introduction: Hyperlipidemia is one of the most important risk factors of ischemic heart disease. Previous studies showed that flaxseed has the potential to improve lipid profiles. In this study we investigated the effect...
Annalisa Berzigotti Annalisa Berzigotti
Non-alcoholic fatty liver disease (NAFLD) is extremely prevalent in the Western world. Non-invasive diagnostic methods should be able to reflect the presence and severity of liver fatty changes and the presence and severity of hepatic infla...
Mario Masarone,Alessandro Federico,Ludovico Abenavoli et al. Mario Masarone et al.
Non Alcoholic Fatty Liver Disease (NAFLD), defined as the presence of a significant amount of lipid accumulation in the liver (at least in 5% of hepatocytes), represents a challenging issue for the Hepatologists. NAFLD is not represented by...
Nicolas Wiernsperger Nicolas Wiernsperger
Hepatic steatosis, a hallmark of non-alcoholic fatty liver diseases (NAFLD), is an early marker as well as a cause of the cardiometabolic syndrome, prediabetes and NIDDM. Its high prevalence in the general population and its many causes and...
Natasa Milosević,Maja Milanović,Ludovico Abenavoli et al. Natasa Milosević et al.
Non-alcoholic fatty liver disease (NAFLD) is a global problem and one of the most common liver diseases in the world. Various pharmacological and non-pharmacological therapies seem to be non-effective and the patients are often advised not ...